Research plan:

Communicable, non communicable diseases, cancer and disabilities

Master and Doctorate thesis:

Master and MD thesis (2014-2016)

Title of the thesis	Degree	Student Name
Treatment results of muscle invasive non metastatic bladder cancer	M.Sc.	Dr. Hanan Ramadan
Prognostic significance of mucin component in rectal carcinoma patients	M.Sc.	Dr. Ghada Zaher
Treatment outcomes and Prognostic factors in  Low Grade Glioma	M.Sc.	Dr. Abdallah Khalil
Chemotherapy versus chemo radiotherapy in locally advanced surgically unresectable pancreatic cancer	M.Sc.	Dr. Eman Mahmoud
Neoadjuvant platinum-based chemotherapy in triple negative breast cancer	M.D.	Dr. Hanan Hamdy
Hypofractionated Conformal Whole Breast Irradiation With Daily Simultaneous Integrated Boost Following Breast Conserving Surgery For Early Stage Breast Cancer	M.D.	Dr. Ahmed Ramadan
Gene Expression of ERCCI As A Novel Predictive Marker in Patients Receiving Platinum-Based Chemotherapy in Advanced Bladder Cancer.	M.D.	Dr. Wesal Eldehona
Evaluation of Three- Dimensional Conformal Breast Irradiation in the Prone Position	M.D.	Dr. Maram Talaat.
Emerging Role of Bevacizumab Combined with Weekly Paclitaxel for Platinum Resistant Ovarian Cancer.	M.D.	Dr. Heba Hassan
Treatment of human Papilloma virus positive oropharyngeal carcinoma by IMRT and IMPT: comparative study	M.D.	Dr. Baher Elgohari
Conformal radiation therapy with concurrent Gemcitabine in treating patients with Glioblastoma Muliforme	M.D.	Dr. Ahmed Abdelhadi
Value of Preablation stimulated thyroglobulin, stimulated Thyroglobulin/ TSH Ratio as a predictor of successful I131 Remnant Ablation in  Differentiated Thyroid Cancer	M.D.	Dr. Asmaa Salem

Master and MD thesis (2017-2021)

************

Title of the thesis	Degree	Student Name
Treatment outcome and prognostic factors in Glioblastoma multiforms	M.Sc.	Dr. Esraa Mohamed Ahmed
Impact Of ablative low dose radioactive iodine after thyroidectomy in low-risk differentiated thyroid cancer	M.Sc.	Dr. Lamiaa Elsaid
Clinico-epidemiological study of Gastric Carcinoma	M.Sc.	Dr. Hadeel Elghamry
Adjuvant treatment in triple negative Breast Cancer	M.Sc.	Dr. Dina Hesham Sabry
Subjective nutritional assessment in cancer patients	M.Sc.	Dr. Hadeel Magdy
Retrospective Epidemiological Study and Prognostie Factors of Renal Cell Carcinoma	M.Sc.	Dr. Yassmina Elborai
Effect of thyroglobulin level before ablative  Radio lodine  on response and survival among  patient with differentiated thyroid Carcinoma	M.Sc.	Dr. Samar Elashry
Impact of delay in radiotherapy and outcomes in breast cancer patients after breast conservative surgery : A retrospective analysis ,Mansoura experience	M.Sc.	Dr. Reham Hammam
Maxillary sinus and  hard palate squamous cell  Carcinoma : Multi _ intuitional experience	M.Sc.	Dr. Elham hussin
Assessment of different Radioactive Iodine Ablation  strategies in intermediate and high Risk Papillary  thyroid Cancer	M.Sc.	Dr. Mohamed Abou Elkheir
Effect of different ablative doses of RAI in patients with differentiated thyroid cancer and cervical LN metastasis A retrospective analysis, Mansoura Experience	M.Sc.	Dr. Mohamed Elsaedy
Survival outcomes and prognostic factors of thymic epithelial tumors. A single center experience	M.Sc.	Dr. Hadeer Abdelrassol
Role of adjuvant treatment in resected extremity soft tissue sarcoma	M.Sc.	Dr. Ahmed Salah
Prognostic factors of testicular cancer: A single institution retrospective study	M.Sc.	Dr. Eman Abdelaziz
The effectiveness of radioactive iodine for treatment of metastatic well differentiated thyroid cancer (10 years study)	M.Sc.	Dr. Walaa Assad
Prognostic value of tumor infiltrating T- lymphocytes (TILs) with special preference to CD8 positive T- lymphocyte in muscle invasive urothelial bladder cancer	M.D.	Dr. Mona Atta
Induction Chemotherapy Followed by Concurrent Chemo- radiotherapy for Locally Advanced Gastro- esophageal and Gastric Carcinoma	M.D.	Dr. Noura Ahmed
The prognostic value  of Androgen  Receptor, cyclin D1,and P53 in breast cancer	M.D.	Dr. Dina Abdelghaffar
Impact of molecular subtypes on 18 FDG PET CTM metastatic Breast Cancer	M.D.	Dr. Ghada Zaher
Prognostic and Predictive  values of  Molecular Subtyping of Metastatic Prostate Cancer	M.D.	Dr. Amal Sayed Ahmed
Total neoadjuvant treatment with short  Course radiotherapy then surgery in locally advanced rectal Cancer: a randomized controlled study	M.D.	Dr. Sara Elzayat

 

Research activities by Faculty:

• Prof. Dr. Hala Elshenshawy

 

Publications:

• Argyrophilic Nucleolar Organizer Regions (Ag NORs), As a Prognostic Factor in Ovarian Carcinoma Treated With Surgery And Combination Chemotherapy, Cyclophosphamide, Adriamycin and Cisplatinum. The Journal of the Egyptian Society of Obstetrics and Gynecology .Vol. 26, No.7, 8, 9, July, August, September, 2000.

• Value of Technetium-99m-MIBI Scintigraphy, Color Doppler Sonography and Mammography in monitoring the response of Locally Advanced Breast Carcinoma to Neoadjuvant Chemotherapy. The Egyptian Journal of Radiology and Nuclear Medicine. Vol.32, No. 3, September 2001.

• The Influence of Patient Geometry on the Selection of Chest Wall Irradiation Techniques in Post-Mastectomy Breast Cancer Patients. Bulletin of Alexandria Faculty of Medicine, Vol.37, No.2, April-June 2001.

• Transcatheter Arterial Chemotherapy of Hepatocellular Carcinoma. Annual Conference of Clinical Oncology and Nuclear Medicine Department, Mansoura Faculty of Medicine, April 2001.

• Alternating Chemotherapy and Accelerated Radiotherapy versus Radical Cystectomy in Treatment Of Muscle Infiltrating Transitional Cell Carcinoma of the Urinary Bladder. The Medical Journal of Cairo University, Vol. 70, No. 4, (Suppl. II) December 2002.

• A Randomized Trial Comparing Neoadjuvant Chemotherapy Followed by Radiotherapy versus Radiotherapy Alone In The Treatment of Patients With Loco regionally Advanced Nasopharyngeal Carcinoma. The Medical Journal of Cairo University, Vol, 70, No. 4, December 2002.

• Gemcitabine/Cisplatin versus Etoposide/Cisplatin in Locally Advanced or Metastatic Non-Small Cell Lung Cancer. The Medical Journal of Cairo University, Vol. 70, No. 2; (Suppl. II) June 2002.

• A Randomized Trial of Sequencing Adjuvant Chemotherapy and Radiotherapy in Lymph Node Positive Premenopausal Operable Breast Cancer. The Medical Journal of Cairo University, Vol. 70, No.2; (Suppl. II) June 2002.

• Acute Changes in Peak Expiratory Flow Rate (PEFR) and Arterial Blood Gases Following Palliative Radiotherapy to the Mediastinum and Large Air Ways. The Medical Journal of Cairo University, Vol.70, No.2, June 2002.

• Biweekly Administration of Irinotecan (CPT-11), 5-Flourouracil and Folinic Acid in Treatment of Advanced Colorectal Cancer. Accepted at the 6th Alexandria International Oncology Conference, October, 2002.

• Weekly Taxol in the Treatment of Metastatic Breast Cancer (MBC) Following Previous Treatment with Anthracyclines. Accepted at the 6th Alexandria International Oncology Conference, October, 2002.

• Primary Gastro-Intestinal Non-Hodgkins Lymphoma; Clinical Features, Management and Prognosis of 56 Patients. The Medical Journal of Cairo University, Vol.71, No. 4, December 2003.

• Combined Chemoradiotherapy Versus Radiotherapy Alone in Patients with Esophageal Cancer. The Medical Journal of Cairo University, Vol.72,No.1, March 2004.

• Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin and Cisplatin in Locally Advanced or Metastatic Transitional Cell Carcinoma of the Bladder. The Medical Journal of Cairo University, Vol. 73, No.4, December 2005.

• Chemotherapy With or Without Radiotherapy in Limited-Stage Aggressive Non- Hodgkin' s Lymphoma. The Medical Journal of Cairo University, Vol.74, No.2, June, 2006.

• Role of Diffusion- Weighted Echo- planar MR Imaging in Differentiation of Residual/ Recurrent Head and Neck Tumors and Post- treatment Changes. Egyptian Journal of Radiology& Nuclear Medicine, Vol.35, No.3, (September): 1397-1405, 2004. American Journal of Neuroradiology (AJNR),vol 28: 1146-52, Jun-Jul 2007.

• The Role of Tc99m-MIBI SPET in Predicting and Monitoring the Chemotherapeutic Response in Primary Lung Cancer. The Medical Journal of Cairo University, Vol. 72,4, December 2004.

• Evaluation of Different Treatment Modalities in Dukes B and C Rectal Adenocarcinoma. The Medical Journal of Cairo University, Vol.72, No.1,March 2004.

• The Effect of a Single Fraction Compared to Multiple Fractions Radiotherapy on Painful Bone Metastases With Evaluation of Computed Tomography Bone Density in Osteolytic Bone Metastases. Bulletin of Alexandria Faculty of Medicine, Vol.42, No.2, 429-440; April-June, 2006. Presented at the Annual Scientific Meeting of the Radiological Society of North America, Radiation Oncology Section, 2005(RSNA-2005), November 27-December 2, 2005, Chicago- USA.

• Evaluation of Hypo-fractionated Radiotherapy in Advanced Non- Small cell Lung Cancer. Presented at the 92nd Scientific Assembly Meeting of the Radiological Society of North America (RSNA-2006), USA, November 26- December1, 2006. The Medical Journal of Cairo University, Vol.73, No.1(S); 177-186, March 2005.

• Adjuvant Hypo-fractionated Versus Conventional Fractionated Radiotherapy in Breast Cancer. The Medical Journal of Cairo University, Vol.74, No.4 September 2006.

• Hypo-fractionated Radiotherapy versus Conventional Fractionated Radiotherapy in Elderly Patients with Glioblastoma Multiforme. Bulletin of Alexandria Faculty of Medicine, Vol.43, No.4, 785-791; October- December, 2007. Accepted and Presented at the 43^rd Annual Scientific Meeting of the American Society of Clinical Oncology, (ASCO - 2007) June 1-5, 2007, Chicago, Illinois, USA.

• Conventional Versus Hyper-Fractionated Radiotherapy In Locally Advanced Head And Neck Cancer. Bulletin of Alexandria Faculty of Medicine, Vol.40, No.2, April-June 2008. Accepted at the Radiation Oncology Session of the 93^rd scientific assembly and annual meetings of Radiological Society of North America (RSNA), Chicago, Illinois-USA, November25-30, 2007. Cancer Therapy Journal; Vol 6, 673-682, December 2008.

• Gemcitabine Plus Docetaxel as First-line Chemotherapy for Metastatic Breast Cancer. Accepted at the Radiation Oncology Session of the 93rd scientific assembly and annual meetings of Radiological Society of North America (RSNA), Chicago, Illinois -USA, November 25-30, 2007.

• Concurrent Chemotherapy with Either Conventional Fractionated Radiotherapy or Accelerated Hyper-fractionated Radiotherapy with Concomitant Boost for Muscle Invasive Bladder Cancer. Accepted at the Radiation Oncology Session of the 93rd scientific assembly and annual meeting of Radiological Society of North America (RSNA), Chicago, Illinois -USA, November 25-30, 2007.

• Induction Chemotherapy with Carboplatin, Paclitaxel Followed by Either Standard Radiotherapy Alone or Concurrent Chemoradiotherapy in Inoperable Stage IIIa or IIIb Non-small Cell Lung Cancer. Accepted at the Radiation Oncology Session of the 93rd scientific assembly and annual meeting of Radiological Society of North America (RSNA), Chicago, Illinois -USA, November 25-30, 2007.

• Weekly Paclitaxel and Paraplatin in Patients with Locoregionally Recurrent Head and Neck Cancer. Accepted for publication at The Medical Journal of Cairo University, at 30/6/ 2007.

• Weekly Paclitaxel and Paraplatin as First Line Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC). Accepted for publication at The Medical Journal of Cairo University, at 30/6/ 2007.

• Gemcitabine plus docetaxel versus docetaxel alone in locally advanced, recurrent, or metastatic breast cancer pre-treated with anthracycline. The Medical Journal of Cairo University, Vol.78, June 2008. Accepted at the 2008 Breast Cancer Symposium of the American Society of Clinical Oncology (ASCO); Published in the 2008 Breast Cancer Symposium Proceedings, Abstract No: 190; September 5-9, 2008, USA.

• Randomized study of docetaxel, cisplatin and fluorouracil versus cisplatin and fluorouracil in patients with advanced gastric or gastroesophageal cancer. The Medical Journal of Cairo University, Vol.76, December 2007. Accepted at the 2008 Gastrointestinal Cancers Symposium of the American Society of Clinical Oncology (ASCO); 25-27 January 2008, published in the 2008 Gastrointestinal Cancers Symposium Proceedings, Abstract No: 112; Orlando, Florida- USA.

• Sequential Chemoradiotherapy Versus Concurrent Chemoradiotherapy Plus Consolidation Chemotherapy In Unresectable Stage III Non-Small Cell Lung Cancer. Bulletin of Alexandria Faculty of Medicine, Vol.40, No.2, June-September 2008. Accepted for publication in the 44^th ScientificAnnual Meeting Proceedings of the American Society of Clinical Oncology (ASCO)-Chicago, Illinois- USA, May 30-June 3, 2008. [J Clin Oncol 26: 2008 (May 20 suppl; abstr 18509)].

• Oxaliplatin, 5-fluorouracil, and Leucovorin in Relapsed or Metastatic Colorectal cancer as a First-line or a Second-line Therapy. The Medical Journal of Cairo University, Vol.74, No.4 September 2009.

• Weekly Paclitaxel Combined with Carboplatin Versus the Standard Every 3-Weeks Paclitaxel and carboplatin for elderly patients with previously untreated Advanced Non-small Cell Lung Cancer. Kaser El-Aini J. Clin. Oncolo. Nucl. Med. Vol. 8, No. 3-4, Jul – Oct. 2011.

• A Randomized Trial of Carboplatin and Weekly Paxlitaxel versus Cisplatin-Cyclophosphamide in patients with advanced ovarian carcinoma: Long-Term efficacy results. Benha Medical Journal. Vol. 29, No. 3 , Sept. 2012.

Current Research:

 

• X-linked Inhibitor of Apoptosis Protein (XIAP) and Phospho-Histone H3 (PHH3) as a proliferation marker in oral squamous cell carcinoma. Is their immunohistochemical expression reliable in predicting prognosis and tumor sensitivity in chemo-radioresistant cases? – 2021.

• The prognostic role of hypoxia and the microenvironmental acidity in chemo-radioresistance in oral carcinoma patients – 2021.

• Prof. Dr. Hanan Wahba

 

Publications

 1- Wahba,H,Khater A.Paclitaxel as induction chemotherapy plus radiation for locally advanced squamous cell carcinoma of the head and neck. Med. J. Cairo Univ.74(4):713-718(2006).

2- Wahba,H.Concurrent chemoradiotherapy wit h low dose gemcitabine in stage III non-small cell lung cancer. Presented at The Second Mansoura Clinical Oncology & Nuclear Medicine Conference “Recent Advances in Oncology”, April 2001, El-Ain El-Sokhna, Egypt

3 - Wahba H, El-Hadaad HA,Dawood T.Adjuvant pelvic radiotherapy vs sequential chemoradiotherapy for high risk stage I-II endometrial carcinoma.Cancer Biol Med 9:168-171(2012).

4-Halim, A. A-F., Mansour, S., Wahba, H., El-Deeb. H. and Hegazy, M. : Head and neck squamous cell carcinoma: Mansoura 10 years experience. Turkish Journal of Cancer, 35: 70-80 (2005).

5-Mansour, S., Galal, K., El-Hendawy, S., Halim, A. A-F., Keshta, S. and Wahba, H.: Oral capecitabine in combination with gemcetabine in management of advanced pancreatic carcinoma. Med. J. Cairo Univ.73: 383-392 (2005).

6- Wahba HA, Abu-Hegazy M , Wasel Y, Ismail E, Shaker A.

Adjuvant Chemotherapy after Reduced Craniospinal Irradiation dose  in Children with Average-risk Medulloblastoma: A 5-year Follow-up Study BUON Sep(2012); 18:425-429

7- Wahba, H., Halim, A. A-F., Eldeeb, H., Alzaafrani, M. and Kandil, T.: Mansoura randomized trial: Irinotecan/de Gramont regimen versus de Gramont regimen alone in chemotherapy-naïve metastatic colorectal carcinoma. Med. J. Cairo Univ. 74:17-24 (suppl) (2006).

8- Halim,.A., Wahba,H., Badrawey,M.,Idaros,M.  and,Denewar,M., :Intraarterial chemotherapy in elderly patients with invasive bladder cancer. . Med. J. Cairo Univ.74:39-46 (suppl) (2006).

9-Halim,A., Wahba,H.,Alshenshawey,H., ,Idaros,M.:Adjuvant hypofractionated versus conventional   fractionated radiotherapy in breast cancer. Med. J. Cairo Univ.74:47-54 (suppl) (2006).

10- Wahba HA, El-Hadaad HA.Gemcitabine and docetaxel as a second-line treatment in advanced soft tissue sarcomas.Clin Oncol Cancer Res;8133-137 Sept(2011 ).

11- Wahba HA, El-Hadaad HA,El-zahaf M, Abu-HegazyM.Radiotherapy in non-functioning pituitary macroadenoma:Mansoura experience.Clin Oncol Cancer Res 8:224-228 Dec (2011).

12- Abo-touk NA, Wahba HA.Neoadjuvant chemotherapy followed by radical surgery in stage IB-IIA cervical cancer:survival and prognostic factors.Zagazig university medical J;16:51-59(2010).

 13- Saleh Y, , Wahba HA, El-Hadaad HA,El-Hemaly M,Youssef T.Adjuvant chemoradiotherapy versus surgery alone for gastric adenocarcinoma.Chinese-German J Clin Oncol;10(8):450-454(2011).

14- Awad I,  Wahba HA, El-Hadaad HA.Low-dose involved-field radiotherapy in relapsed low grade non-hodgiken lymphoma in elderly patients(Mansoura university experience).Accepted for poster presentation during the ESMO 2012 congress 28Sept-2 October Vienna,Austria.published in J of cancer therapy May 2014;5:500-505

15- Halim AA, Wahba HA.Second-line neoadjuvant vinorelbine and gemcitabine combination in locally advanced breast cancer showing no early response to TAC .Med Oncol 29:454-458 June (2012).

16- El-Shahat M,Abdallah M,Sharaf Eldeen D, Wahba HA, Saleh Y.B2 colon cancer:Is there role for adjuvant chemotherapy? Mansoura experience .Med. J.Cairo Univ. 77:56- (2009).                                                                     

17- Hanan A. Wahba , Hend A. El-Hadaad , Sameh Roshdy. Combination of Irinotecan and 5-fluorouracil with Radiation in Locally Advanced Rectal Adenocarcinoma. J Gastrointest Cancer Sept (2012) 43:467–471 DOI 10.1007/s12029-011-9350-5

18-Hend A. El-Hadaad, Hanan A. Wahba, Eman Toson. Induction chemotherapy followed by weekly paclitaxel and carboplatin with concurrent radiotherapy in inoperable stage III non-small cell lung cancers: results of a phase II trial. Chinese-German Journal of Clinical Oncology Feb 2013, Volume 12, Issue 2, pp 56-60 DOI 10.1007/s10330-012-1087

19- Hend Ahmed El-Hadaad & Hanan Ahmed Wahba.  Oxaliplatin Plus 5-Fluorouracil and Folinic Acid (OFF) in Gemcitabine-Pretreated Advanced Pancreatic Cancer: A Phase II Study. J Gastrointest Canc Sep (2013) 44:313–317 DOI 10.1007/s12029-013-9495-5

 20- Wahba HA, Halim A, El-Hadaad HA. Irinotecan plus cisplatin chemotherapy followed by concurrent thoracic irradiation with low-dose weekly cisplatin for limited-disease small-cell lung cancer.Med Oncol. 29(1):199-204( 2012).

21-Halim A, Wahba HA, El-Hadaad HA, Abo-Elyazeed A. Concomitant chemoradiotherapy using low-dose weekly gemcitabine versus low-dose weekly paclitaxel in locally advanced head and neck squamous cell carcinoma: a phase III study.Med Oncol. 29(1):279-284 ( 2012) .

22-Halim A, Wahba H. Cisplatin-ifosfamide combination chemotherapy in metastatic triple-negative, anthracycline- and taxane-pretreated breast cancer patients; a phase II study.J BUON. 17(2):254-258 Jan(2012 ).

23- Mohamed Elawadi, Hend Ahmed El-Hadaad, Hanan Ahmed Wahba, Hosam Ghazy, Amro ELhadidi.  Does Surgical Resection of the Primary Tumor in Patients with Stage IV Breast Cancer Improve Survival? American Journal of Cancer Therapy and Pharmacology Jan 2014, 2:1-7

24- El-Hadaad HA, Wahba HA, Roshdy S. Concomitant chemoradiotherapy with Cisplatin plus 5-Fluorouracil for anal squamous cell carcinoma. J Gastrointest Cancer. 2015 Jun;46(2):156-60. doi: 10.1007/s12029-015-9707-2.

25-. HA Wahba, HA El-Hadaad. Current approaches in treatment of triple-negative breast cancer - Cancer biology & medicine, June 2015;12:106-116

26 - HA Wahba, HA El-Hadaad, WN Abozeed. Survival and Prognostic Factors in Patients with Carcinoma of Cervical Stump‏  Journal of Cancer therapy Oct 2015;6:1008-1012

27- H EL-Hadaad, H Wahba, S Roshdy, A Gamal .Concurrent pelvic radiation with weekly low-dose cisplatin and gemcitabine as primary treatment of locally advanced cervical cancer: A phase II study.‏  International Journal of Cancer therapy and oncology,July 2015;3:1-5

28- Salah-Eldin MA, Wahba HA, Halim A.Biweekly pegylated liposomal doxorubicin/oxaliplatin for ovarian cancer resistant to taxane-platinum treatment: a Phase II study.Indian J Cancer. 49(1):169-175,July (2012).

29-Hanan A Wahba and Mohammed Abu-Hegazy.Single-versus multi-fraction radiation treatment for metastatic spinal cord compression:functional outcome study.Chinese-German J of Clinical Oncology 10;9:535-540 Sep (2011).

30-Wahba HA,El-Hadaad HA,Abd-Ellatif EA .Neoadjuvant concurrent chemoradiotherapy with capecitabine and oxaliplatin in patients with locally advanced esophageal cancer.Med Oncol 29:1693-1698 Sep (2012)

31-Hala M El-shenshawy,ElSayed M Elhindawy,Saleh M Taema and Hanan A Wahba.Evaluation of hypofractionated radiotherapy in advanced non-small lung cancer. Med. J.Cairo Univ 73;177-186 March 2005

32-Idaros M ,El-Hagracy S,El-Far A,Yousry A,Wahba H.Whole brain radiotherapy as palliative treatment of brain metastases.The Egyptian J of neurology,psychiatry and neurosurgery 43(2):529-538 July 2006

33-Elzahi MS, Mohamed Elawadi,Awad I,Wahba H.Concurrent chemoradiation of patients with inoperable non-metastatic pancreatic cancer. Med. J.Cairo Univ 81(2): 29-34 March 2013

34- H EL-Hadaad, H Wahba, Hayam Fathy Abd-El Hay Ghazy.

 Metastatic Renal Cell Carcinoma: Sunitinib as First-Line Treatment; Results of a Retrospective Study.Forum of clinical oncology 6(4):23-27,2015

35-A Halim,HA Wahba,HA El-Hadaad,A Wafa,A Elhadidi and H Halim.Thyroid cancer and thyroid disorders in adolescent:5-years experience.Clin Oncol 1;1167,2016

36- HA Wahba,HA El-Hadaad.Concurrent versus sequential chemoradiotherapy for locally advanced resectable hypopharyngeal carcinoma.International journal of cancer therapy and oncology 4(3):4111, 2016

37-El-Hadaad HA, Wahba HA, W Elnahas,Roshdy S.Concomitant boost radiotherapy after conservative breast surgery in early breast cancer.Advances in breast cancer research 5(03):97,2016

38- Hend A EL-Hadaad, Yasser M Saleh,Hanan A Wahba and Magda A Ahmad.Advanced Non-Small Cell Lung Cancer: Retrospective Study of Prognostic Factors .J Lung Cancer Diagn Treat, Volume 2 • Issue 1 • 1000112(2:112),2017

39-Mohamed Sarhan, Amal Halim,Ibrahim Elzayat, Tamer Saber,Amira El-Hawary, Adel El-Badrawy, Hanan Wahba, Hend El-Hadaad,Omar Farouk and Wagdi El Kashif Pediatric and Adolescent Malignant OvarianTumors:Mansoura 5 - Year Experience .Journal of Cancer and Tumor International6(2): 1-10, 2017

40- Halim A, Wahba H .Partial Breast Irradiation : An amazing         art as Oral &Poster Presentation in 9thBGICC, held on 19-20 January,2017

41- El-Hadaad HA, Wahba HA, WN Abozeed ,W Elnahas,Roshdy S.Exocrine Pancreatic Cancer :A Clinico-epidemiologic Study.Journal of Cancer and Tumor International 7(3):1-7,2018

42-Alaa M. Wafa, Hanan A. Wahba,Hend A. El-Hadaad, Amro Elhadidi,

Hosam Halim.Predictors of recurrent thyrotoxicosis in a cohort of Egyptian thyrotoxic patients treated with radioactive iodine. Egyptian Journal of Obesity, Diabetes and Endocrinology;4:1–4,2018

43- Hanan Ahmed Wahba, Hend Ahmed El-Hadaad, Abeer Hussien Anter, Alaa M. Wafa,Ahmed Negm. Impact of Thyroglobulin on Survival and

Prognosis of Differentiated Thyroid Cancer. Journal of Cancer Therapy; 9, 706-13,2018

44-Hanan Ahmed Wahba, Hend Ahmed El-Hadaad, Abeer Hussein Anter, Magda Abdel-Salam Ahmad, Hayam Fathy Abd-El Hay Ghazy. Outcomes and Prognostic Factors of Small Cell Lung Cancer: A Retrospective Study.Advances in Lung Cancer; 7:21-31,2018

45-Hend Ahmed EL-Hadaad, Hanan Ahmed wahba, Hisham Abdrabuh A ALthobaiti and Abdulrahman R Alrubayee. Hormonal Therapy in Gynecologic Malignancy. Cancer Sci Res. 2019; 2(2); 1-6.

46-Mohamed Adelsalam, Mohamed Abu-Hegazy, Hend Ahmed EL-Hadaad Hanan wahba,Hossam Egila and Ahmed Esmael.Pathophysiology,Mechanism, and Outcome of Ischemic Stroke in Cancer Patients.J Stroke Cerebro-vasc Dis 2020;29(11):1-10

47-Adel El-Badrawy, Ahmed Tawfik, Gehad Saleh1Mai Abdel-Naby, Hayam Ghazy, Ziad Emarah, Ahmed Ramez,Mohamed A. Elfatah, Ahmed Eltantawy, Mona M. Taalab, Noha Eisa, Shaimaa El-Ashwah, Yasmine Essam,Basma Atef, Shahira Ali El-Etreby4, Monir H. Bahgat, Ahmed Deiab, Hatem Elalfy, Tarek Besheer, Ahmed El-Mesery, Mohamed Mahmoud Sarhan, Suzy Abd Elmabood,Ahmed Megahed, Mohamed Farouk Akl, Khaled Abouelkhair, Hanan Wahba, Amal Halim, Nirmeen Megahed and Eman Omar Khashaba.

MDCT Evaluation of Hepatic Manifestations in Malignant Hematological

Disorders.Cardiovascular Disorder and Medicine. doi:10.31487/j.CDM.2020.02.01 Volume 2(2): 2-6

48-Manal M S ELgareeb,Hanan A Wahba,Ahmed El-Demeri,Mohamed Elashry,Rasha Abd El Ghany Khedr.Hypofractionated radiotherapy using simultaneous boost technique with concurrent and adjuvant temozolamide for glioblastoma.Journal of Cancer and Tumor International 2020;10(4):16-23

49-Hayam Fathy Ghazy, Hend Ahmed El-Hadaad, Hanan Ahmed Wahba, Ramy Abbas & Osama A. Abbas . Metastatic Esophageal Carcinoma: Prognostic Factors and Survival. Journal of Gastrointestinal Cancer (2021) . https://doi.org/10.1007/s12029-021-00610-4

Scientific activities:

1-Books:

Book title: Frontiers in Radiation Oncology   )ISBN  978-953-51-1163-4(

Chapter title: locally advanced esophageal cancer

Authors: Hend El-Hadaad and Hanan Wahba

2-Reviewer: of scientific peer- reviewed articles in Zagazig University Medical Journal

  

 

• Prof. Dr. Amal Fouad

Publications

1-El-Awadi, M. M., El-Kholy, N. M., El-Laithy, R. and Halim, A. A-F.:

Clinico-Epidemiological study of Non-Hoggkin’s lymphoma with identification of prognostic factors. Mans. Med. J., 29:185-203 ,1999.

2-Eita, M., El-Kholy, N., El-Dosoky, M., Kandel, A. and Halim, A.

Role of chemoradiotherapy in inoperable non small cell lung cancer.  Presented at The Second Mansoura Clinical Oncology & Nuclear Medicine Conference “Recent Advances in Oncology”, April 2001, El-Ain El-Sokhna, Egypt

3-El-Hanafy, O.A., Halim, A. A-F., Fowler, J. F. and Tannehill, S. P.     High dose rate brachytherapy fractionation effect on biological effective dose for patients treated with carcinoma of uterine cervix.  Presented at “African Radiation Oncology Group II Conference, Dec. 2003, Cairo,Egypt.

4-Mansour, S., Galal, K., El-Hendawy, S., Keshta, S., Halim, A. A-F. and Ahmed, K.: The therapeutic outcome of multimodality approach in management of locally advanced , Stage III and IVa invasive thymoma.  Med. J. Cairo Univ., 72 (Suppl.): 231-245 ,2004.

5-Halim, A. A-F., Mansour, S., Wahba, H., El-Deeb. H. and Hegazy, M. : Head and neck squamous cell carcinoma: Mansoura 10 years experience. Turkish Journal of Cancer, 35: 70-80 ,2005.

6-Mansour, S., Galal, K., El-Hendawy, S., Halim, A. A-F., Keshta, S. and Wahba, H.: Oral capecitabine in combination with gemcetabine in management of advanced pancreatic carcinoma. Med. J. Cairo Univ.73: 383-392 ,2005.

7-Halim, A. A-F. and Abd Alsamad, A.: Baroreflex Failure: A late radiotherapy complication neglected by radiotherapists. Med. J. Cairo Univ. 73: 99-105 ,2005.

8-Hegazy, M., Hegazy, R., Elshafei, M., Setit, A., Elshamy, M., Eltatoongy, M. and Halim, A. A-F: Neoadjuvant chemotherapy versus primary surgery in advanced ovarian carcinoma. World J. Surg. Oncol. 3: 57-64 ,2005..

9-Wahba, H., Halim, A. A-F., Eldeeb, H., Alzaafrani, M. and Kandil, T.: Mansoura randomized trial: Irinotecan/de Gramont regimen versus de Gramont regimen alone in chemotherapy-naïve metastatic colorectal carcinoma. Med. J. Cairo Univ. 74:17-24 (suppl) ,2006.

10- Halim,.A., Wahba,H., Badrawey,M.,Idaros,M.  and,Denewar,M., :Intraarterial chemotherapy in elderly patients with invasive bladder cancer. . Med. J. Cairo Univ.74:39-46 (suppl) ,2006.

11-Halim,A., Wahba,H.,Alshenshawey,H., ,Idaros,M.: Adjuvant hypofractionated versus conventional   fractionated radiotherapy in breast cancer. Med. J. Cairo Univ.74:47-54 (suppl) ,2006.

12-Halim,A.,khater,A., Youssef,T., Ghazy,H., Alhawary,A.,:  Preoperative concurrent chemotherapy in locally advanced rectal cancer using an oxaliplatin- containing regimen : A phase II Study.Med. J.Cairo Univ.75:201-209(suppl),2007.

13-Daoud,M.,Halim,A.,Elsherbiny,E.,Abdel-Hady,E.,: Single agent carboplatin versus combination chemotherapy in advanced ovarian carcinoma:An Egyptian institute experience.  Pan Arab Med. J. 2: 19-27 ,2007.

14-Halim, A., Abdallah, T. and Khater, A.:  Phase II study of concurrent paclitaxel, cisplatin and radiotherapy as preoperative treatment for patients with resectable thoracic esophageal carcinoma.  Med. J. Cairo Univ. 75:43-49 ,2007.        

15-Tantawy,M., Abd el-gaber,N., Halim,A.,etal.:Computedtomograghy assessment of radiation induced lung disease and mimicking conditions.TheEgypian J. of Radiol&Nuc.Med .38:1275-1284,2007.

16-Saleh, Y., Al-Shahat,M., Halim,A.,etal.;Prognostic role of matrix metalloproteinase-9 in patients with osteosarcoma. Med. J.Cairo Univ. 76:115-120,2008.

17-  Abd  El-Naby   , El-Shenshawy H .,   Halim A.,Hamdy  R: Conventional versus hyperfractionated radiotherapy in locally advanced head and neck cancer.Cancer Therapy 6:1-5, 2008.

18-Makharita,M., Halim,A., and Abo-elyazeed ,A.,:Can stellate ganglion block improve the result of suprascapular nerve block in post mastectomy patients? Eg J Anaesth 25:11-19 ,2009.

19-Nadia A Hasaneen, Fathy  A , Halim A ,  Magdi D

Quanti-FERON-TB Gold for detection of latent and active tuberculosis infection in immunocompromised  versus immune-competent patients.Egyptian Journal of chest disease and tuberculosis59:34-39,2010.           

20-Amal AF Halim. Palliative       Hypofractionated radiotherapy for elderly patients with locally advanced  head and neck squamous cell carcinoma  having score 2 performance status. Zagazig University Medical Journal 3:92-99 (2010).

21-Youssef  L,Azmy E  ,Halim A  ,Rabie A ,El-Gayar  A  :  The prognostic value of interleukin-8 in adult patients with aggressive Non Hodgkins lymphoma. The Egyptian   Journal of Hematology36:33-38 ,2011 .

22-Halim A, Ebrahim MA, Saleh Y. A phase II study of outpatient biweekly gemcitabine-oxaliplatin in advanced biliary tract carcinomas.Jpn J Clin Oncol. 41(2):217-224,2011 .

23- Wahba HA, Halim A, El-Hadaad HA. Irinotecan plus cisplatin chemotherapy followed by concurrent thoracic irradiation with low-dose weekly cisplatin for limited-disease small-cell lung cancer.Med Oncol. 29(1):199-204, 2012.

24-Halim A, Wahba HA, El-Hadaad HA, Abo-Elyazeed A. Concomitant chemoradiotherapy using low-dose weekly gemcitabine versus low-dose weekly paclitaxel in locally advanced head and neck squamous cell carcinoma: a phase III study.Med Oncol. 29(1):279-284 , 2012 .

25-Halim A, Wahba H. Cisplatin-ifosfamide combination chemotherapy in metastatic triple-negative, anthracycline- and taxane-pretreated breast cancer patients; a phase II study.J BUON. 17(2):254-258(2012 ).

26-Laila F. Youssef, Emad EldinAzmy, Amal A.F. Halim, Ahmed M. Rabie and Amal M. El-Gayar:Serum platelet-derived growth factor-BB in adult patients with aggressive non-Hodgkin’s lymphoma. Egyptian Journal of Haematology, 37 (2):135-139,2012.

27-Halim A, Abotouk N. Methotrexate-paclitaxel-epirubicin-carboplatin as second-line chemotherapy in patients with metastatic transitional cell carcinoma of the bladder pretreated with cisplatin-gemcitabine: A phase II study.Asia Pac J Clin Oncol.9(1):60-5. doi: 10.1111/j.1743-7563.2012.01554.x.,2013

28- Halim A, Mansour S. Induction chemotherapy by capecitabine and oxaliplatin (CAPOX) followed by concurrent capecitabine and radiotherapy for rectal carcinoma recurrence in patients with prior pelvic irradiation. Journal of Gastrointestinal   Oncology doi:10.3978/j.issn.2078-6891.2012.035  .

29 -Halim A.Treament outcome and prognostic factors of non metastatic squamous cell carcinoma of anal cancal:Experience from a single institution.Accepted for publication in the  Turkish Journal of Cancer on 10-9-2012 ( in press).

30- Halim A. Metronomic capecitabine for elderly advanced gastric carcinoma patients pretreated with one or two systemic chemotherapy lines. Benha Medical Jornal  29:195-211,2012 .

31-  .Halim A,ElashryR,SolimanO,Sarhan O .Bilateral Wilms tumor:Mansoura multi-centers  15  years experience.Oncol Pharm pract18(1):115-121,2012

32- Salah-Eldin MA, Wahba HA, Halim A.Biweeklypeglated liposomal doxorubicin/oxaliplatin for ovarian cancer resistant to taxane-platinum treatment: a Phase II study.Indian J Cancer. 49(1):169-175, (2012).

33-Halim A.The effect of multiplicity of metastatic sites on hormone refractory prostate cancer. Middle East Journal Of Cancer 3(4):101-108,2012.

34-  Allam M,EtebaS,HalimA,TemrazS,Osman A:Neoadjuvant Chemotherapy Followed By Conformal Hypofractionated Radiotherapy withConcurrent Gemcitabine in Muscle - InvasiveBladder Cancer.American Journal of Cancer Therapy and Pharmacology . 2(1):33-47,(2014).

35-Amal Halim ,Hanan Wahba:Partial breast irradiation:An amazing art.Accepted for oral presentation in The ^8th Breast Gynecological International Cancer Conference(BGICC) supported by ESMO.Fermont Heliopolis Hotel,19^th -20^th  Jan.2016,Cairo,Egypt.

  36-A Halim, HA Wahba, HA EL-Hadaad, A Wafa, A ELhadidi, H Halim.Thyroid Scan and Thyroid Disorders in Adolescent: 5-year Experience.Clin Oncol 1, 1167-1170,2016.

37-Dina Abd-El-Ghaffar,Mohammed Farouk Akl,AmalHalim,MahfouzEita.:Outcome and predictive factors of radiation therapy for medulloblastoma:MansouraExperience.Journal of cancer and tumor international.5(3): 1-11,2017.

38-Mohamed Sarhan, Amal Halim, Ibrahim Elzayat, Tamer Saber,Amira El-Hawary, Adel El-Badrawy   ,Hanan Wahba, Hend-Elhadaad, Omar Farouk   ,and Wagdi El Kashif .Pediatric and adolescent malignant ovarian    tumors: Mansoura 5 - year experience.Journal of Cancer and Tumor International.6(2):1-10,2017.

39- Hany Ammar, ohammedElywa, Amal Halim and Shaimaa Elnabawey.: A comparative dosimetricstudy on three-dimensional conformal radiation treatment and multisegmented conformal radiation treatment for breast cancer.World Journal of Medical Sciences 15 (1): 48-57, 2018.ISSN 1817-3055.© IDOSI Publications, 2018.DOI: 10.5829/idosi.wjms.2018.48.57.

40-Halim H, Halim A and Hamed RH.:Young Population Attending for Whole BodyTechnetium 99MDP Bone Scintigraphy: A SingleInstitution ExperienceJ Bone Biol Osteoporosis, 4(1): 68-73 ,2018.

41-RashaHamdy,AmalHalim:Squamous cell carcinoma of oral tongue  in our locality: A single institution retrospective cohort study.Indonesian Journal  of  cancer. 12(4), 102-8, January 2019.

42-Amal Halim, Niveen Abo-Touk, Nahla Mokhtar , Hadeel Elghamery , Eman Ismail:Uterine carcinosarcomas versus leiomyosarcomas: DuaL Institutional experience from Mansoura and Zagazig universities. Journal of Cancer and tumor international. 9(3):1-10,2019.

43-Eman Ibrahim,FatmaElsaeed,EnasabdElgalil and HosamHalim:Medullary thyroid carcinoma metastatic to breast :Case report.Journal of Cancer and tumor international. 9(3):1-6,2019.

44- Maha A. El-Gayyar,MD ,Manar E. Sallam,MD,  Mohamed Khaled    ,MD, Mohamed H. El-Mougy,   MD, Amany A. El-Hawwary2    , MD, Amal AF  Halim    ,MD,Hala El Shenshawy, and  Adel El-Badrawy.Langerhanscell histiocytosis:Clinical,histopathological and radiological case series study: An institutional experience. Asian Oncology Research Journal3(1): 6-19, 2020; Article no.AORJ.54099.

45-Amir M zaid,Engy M Aboelnaga, AmalHalim, Mohamed Abdelkhalek,Salah S Elbalka,MohamedZuhdy,Ahmed M Fareed,Eman M Ibrahim,HosamHalim,Islam H Metwally:Rectal cancer among younger Egyptian patients-clinicao-pathological features and oncologic outcomes:A single institution experience.memo-Magazine of European Medical Oncology13,314-323,2020.

46-Adel El-Badrawy*, Ahmed Tawfik, Gehad Saleh, Mai Abdel-Naby1, HayamGhazy, Ziad Emarah, Ahmed RamezMohamed A. Elfatah, Ahmed Eltantawy, Mona M. Taalab, NohaEisa, Shaimaa El-Ashwah, Yasmine Essam,Basma Atef, Shahira Ali El-Etreby, Monir H. Bahgat, Ahmed Deiab, Hatem Elalfy, Tarek Besheer, Ahmed ElMesery, Mohamed Mahmoud Sarhan, Suzy Abd Elmabood, Ahmed Megahed, Mohamed Farouk Akl, KhaledAbouelkhair, Hanan Wahba, Amal Halim, NirmeenMegahed and Eman Omar Khashaba:MDCT evaluation of hepatic manifestations in malignant h ematological disorders.Cardiovascular Disorder and Medicine doi:10.31487/j.CDM.2020.02.01Volume 2(2): 2-6,2020

47-Eman M. Ibrahim, Salma S. El Ashwah, Fatma I. El-Saeed,

Hosam A. F. Halim ,Amal A. F. Halim.Postmenopausalbleeding with an accidentaldiscovery of an ovarian strumalcarcinoid tumor: Acase report.Journal of Cancer and Tumor International

11(1): 20-24, 2021; Article no.JCTI.65177.ISSN: 2454-7360.

48-Manal MS Elghareeb1, Mona YY Abd Allah 2, Sieza S Abdallah3, Ahmed R Eldesoky1, Amal AF Halim1*:Sacral chordoma with bilateral inguinal lymph node metastasis and metachronous tumor of the clivus: A case report.Journal of Orthopaedic Case Reports : 11(5):Page 1-3,2021.

 

Scientific activities:

-Referee for  several journals  as Oncotargets and Therapy,Breast  Cancer Targets and Therapy,Cancer Management and Research,Journal of Cancer and Tumor International,andTherapeutics and Clinical Risk Management.

Current research

1-The prognostic value of Androgen Receptor, cyclin D1, and P53 in infiltrating duct carcinoma of the breast.

2- Maxillary sinus and hard palate squamous cell carcinoma:Multi-institutional experience.

3- Invasive micropapillary carcinoma of ampulla of Vater in a young female: A case report

Google schooler site

https://scholar.google.com/citations?user=oc3AvqQAAAAJ&hl=en

Mymans

https://mymans.mans.edu.eg/home/categories/1.tbstaffSystem/1.10.tbstaffSystem

 

• Prof. Dr. Ghada Ezzat

 Publications:

1-Do we need to treat patients with Glioblastoma Multiforme with radical chemoradiotherapy if they had biopsy alone? Northampton Experience. Forum of Clinical Oncology ,issue 2, vol.3, p 28-34, June 2012.

2-Treatment of elderly breast cancer: Mansoura Experience

Pan Arab Journal of Oncology, vol.5 issue 2 , P 16-21,June  2012.

3- Second Line Treatment With Oxaloplatin, Folinic Acid and 5-Fluorouracil (Off) In Gemcitabine Refractory Advanced Pancreatic Carcinoma. The medical journal of Cairo university, Vol. 80 No.1, P271–P275,  june 2012.

4- B-Catenin and Matrix Metalloproteinase-7 Expression in Deep Fibromatosis: Impact on Local Recurrence. Egyptian Journal of Pathology,Vol. 32,Issue 1,P 26-32, July 2012.

5- Do Concurrent Chemoradiotherapy With Docetaxel Followed by Docetaxel Consolidation Chemotherapy Improve Outcome Of Anaplastic Thyroid Carcinoma Patients?  Forum of Clinical Oncology, issue 2, vol.4, p 24-30, June 2013.

6- Preoperative Capecitabine and pelvic radiation in locally advanced rectal cancer: preliminary results (Mansoura Experience) Translational Gastrointestinal Cancer, 2 (3): 112-117, 2013.

7- Low risk trophoblastic neoplasia: outcome after initial treatment with single agent intramuscular methotrexate and oral folinic acid.

The medical journal of Cairo university  Vol 82 March 2014.

8- Re-irradiation in recurrent rectal cancer: Single institutional experience

 Transl Gastrointest Cancer 2014; 3(2):73-79.

9- High dose conformal radiotherapy in stage III non-small cell lung cancer: A feasibility study. The medical journal of Cairo University Vol 82 March 2014.   

10-Adjuvant Chemo-Radiotherapy versus Chemotherapy in Pancreatic Carcinoma. RESONCOL.2017.1093.1027

11- Prospective evaluation of weekly concomitant tumor bed boost with three-week hypofractionated whole breast irradiation in early breast cancer. J Radiat Oncol (2017) 6:93–99.

12- Prognostic significance of mutant IDH1, CD133 and β-catenin immunohistochemical expression in glioblastoma multiforme. Egyptian Journal of Pathology, vol. 38(1):27-34,July 2018.

13-Local Consolidation Therapy versus Observation for Oligometastatic Non Small Cell

Lung Cancer Patients: Phase II Randomized Trial. Journal of Cancer Therapy, 2018, 9, 925-940.

14- The Lower Peripheral Blood Lymphocyte to Monocyte Ratio Following Completion of First

Line Chemotherapy Is a Risk Factor for Predicting Relapse in Patients with Diffuse Large B-Cell Lymphoma. Journal of Cancer Therapy, 2019, 10, 53-68.

15- Impact of Neoadjuvant Chemotherapy on Breast Cancer Biomarkers: A Guide for Further Adjuvant Treatment. Cancer Research Journal 2019; 7(1): 8-17.

16- Management of stage IB grade III endometrial cancer. Single institute experience

Journal of Cancer Therapy, 2019, 10, 290-304.

17- Localised prostate versus whole pelvic irradiation in high risk prostate cancer, single institute experience. Cancer Research Journal 2019; 7(1): 18-24.

18-3D conformal re-irradiation with Temozolamide for recurrent Glioblastoma: a prospective cohort study. Journal of Cancer Therapy, 2019, 10, 619-631.

 Published Book Chapter in Current Topic in Medicine and Medical Research 2020.

Local Consolidation Therapy versus Observation for Oligometastatic Non Small Cell Lung Cancer Patients: Phase II Randomized Trial.

Reviewer in Journal of Pharmaceutical Research International  2021.

 

• Prof. Dr. Engy Mossad

 

PUBLICATIONS:

1) M.Sc. thesis (Different Chemotherapy Modalities in Locally Advanced Non-Small cell Lung Cancer) in 2004.

2) M.D thesis (Preoperative Radiotherapy In Comparison With Postoperative Radiotherapy in Resectable Rectal Cancer) in 2010.

3) Published scientific paper in journal of Egyptian National Cancer Institute (Preoperative Radiotherapy In Resectable Rectal Cancer: A Prospective Randomized Study of Two Different Approaches) in September 2010: 22(3);155-164, 2010.

4) Published scientific paper in journal of Cairo university (Vinorelbine plus Capecitabine in patients with metastatic breast cancer pretreated with Anthracyclines and/or Taxanes: The clinical experience at Mansoura University in Egypt) in March 2012: 80(2); 169-174.

5) Published scientific paper in Cancer Biology & medicine journal (Male breast cancer: 10 years experience at Mansoura University Hospital in Egypt) in March 2012; 9:23-28.

6) Published scientific paper in Pathology and Oncology research journal (Thyroid Cancer in Egypt: Histopathological Criteria, Correlation with Survival and Oestrogen Receptor Protein Expression) in January 2015.

7) Published scientific paper in Cancer Biology & medicine journal (Difference between papillary and follicular thyroid carcinoma outcomes: An experience from Egyptian institution) in March 2015; 12(1):53-59.

8) Published scientific paper in medical oncology journal (Induction FOLFOX followed by preoperative hyperfractionated radiotherapy plus bolus 5-fluorouracil in locally advanced rectal carcinoma: single arm phase I–II study) in March 2015:32; 108.

9) Published scientific paper in medical oncology journal (Early parathyroid hormone laboratory abnormalities related to therapeutic radiation of neck: an Egyptian experience) in April 2015.

10) Accepted poster presentation in EANM’15 - Annual Congress of the European Association of Nuclear Medicine (October 10 - 14, 2015 in Hamburg/Germany) titled (Role of MUGA scan in diagnosis of cardiotoxic effect of trastuzumab (Herceptin) on global and segmental left ventricular myocardial walls in patients with breast cancer).

11) Published scientific paper in Cancer Biology & medicine journal (Second-line panitumumab as a triweekly dose for patients with wild-type KRAS exon 2 metastatic colorectal cancer: a single institution experience) in 13(1):136-41, March 2016.

12) Published scientific paper in International Journal of Cancer Therapy and Oncology (Involved-site radiation therapy by volumetric modulated arc therapy versus 3D-conformal radiotherapy for treatment of stages I and II supra-diaphragmatic Hodgkin’s lymphoma) in Vol 4, N0 (3), August 2016.

13) Published scientific paper in OncoTargets and Therapy (Clinical outcome and toxicity evaluation of simultaneous integrated boost pelvic IMRT/VMAT at different dose levels combined with androgen deprivation therapy in prostate cancer patients) in 10 4981–4988,12 October 2017.

14) Accepted poster presentation in Emirates Oncology Conference 2017 (Simeltaneous integrated boost by volumetric modulated arc therapy (VMAT) with concurrent mitomycin and capecitabine in anal canal carcinoma) in November 2017.

15) Rasha Hamdy Hamed, Engy Aboelnaga. Brief palliative radiotherapy course for advanced and incurable head and neck cancer. Int J Radiol Radiat Oncol 2018 4(1): 014-018.

16) Engy M Aboelnaga, Rasha Hamdy Hamed, Amir M zeid and Amrallah A Mohammed. Neoadjuvant Platinum and Gemcitabine Regimens Precede Definitive Radiotherapy in Locally Advanced Bladder Cancer. Cancer Science & Research: Open Access 2019 5(2): 1-8.

17) Engy Aboelnaga, Salwa Fathy, Mohamed Daoud. Simeltaneous integrated boost by volumetric modulated arc therapy (VMAT) with concurrent mitomycin and capecitabine in anal canal carcinoma). Middle East Journal of Cancer; July 2019; 10(3): 183- 193. Accepted poster presentation in Emirates Oncology Conference 2017.

18) Mohd Shafi Moona, Amal M Ismail, Ahmed A Zeeneldine, Wael M

Mohamed, Engy Aboelnaga. Invasive ductal carcinoma of male

breast in a relatively young patient. International Journal of Medical

and Health Research; May (3)2017;46-47.

19) Wael Mohamed, Ashraf Fouda , Heba Goma ,Nasser Al-Dhaibani ,

EngyAboelnaga , Hafez Ghanem. Current status of palliative care

service to terminally ill patients (physician perspective in Middle

East). Accepted poster presentation in Emirates Oncology

Conference 2017.

20) Engy Aboelnaga, Wafaa El-beshbesh. Comparative study of low

dose of capecitabine versus standard dose in metastatic breast

cancer: Efficacy and safety. Accepted for publication in Forum of

Clinical Oncology at May 4th, 2020.

21) Amir M. Zaid , Engy M. Aboelnaga, Amal Halim, Mohamed

Abdelkhalek, Saleh S. Elbalka, Mohamed Zuhdy , Ahmed M. Fareed,

Eman M. Ibrahim, Hosam Halim, Islam H. Metwally. Rectal cancer

among younger Egyptian patients—clinicopathological features

and oncologic outcomes: A single institution experience. Memo -

Magazine of European Medical Oncology published on line at May

26 th, 2020.

22) Wafaa El-beshbeshi; Amir M. Zaid; Osama Eldamshety; Islam H.
Metwally; Entesar Aladl; Engy Aboelnaga. Prognostic Significance
of Lymph Node Ratio after Cervical Lymph Node Dissection in
Head and Neck Squamous Cell Carcinoma. Research in Oncology
2020; Vol. 16,No. 1: 22-30.published on line at June 29 th, 2020.

23) Omar Hamdy , Mahmoud M. Saleh , Mohammed H. Ros • Amir
Mosaad , Shadi Awny , Engy M. Aboelnaga, Islam H. Metwally.
Epidemiology and predictors of survival of tongue cancer among
Egyptians in the Delta region. Published on line 9 January 2020 in
memo - Magazine of European Medical Oncology.

24) Omima Elemam, Seham Abdelkhalek, Doaa Abdelmoety,, Engy
Aboelnaga, Reem Baraka, Ahmed Zeeineldin. Sequential Chemoradiotherapy Compared to Radiotherapy in Endometrial
Carcinoma. Asian Pacific Journal of Cancer Prevention 2020, 21 (5),
1327-1332.

25) Khaled Gaballa, Mohamed Abdelkhalek, Basel Refky,,Basma
Gadelhak, Engy M.Aboelnaga , Wafaa El-Beshbishi . The Impact of
Obesity on Surgical Complications and Disease Recurrence in
Endometrial Cancer: A Retrospective Study of 267 Patients.
Research in Oncology 2020; Vol. 16,No. 1: 11-14.

 

• Prof. Dr. Khaled AbouElkhair

Publications:
1) M.Sc Thesis (Evaluation of different treatment modalities in laryngeal
cancer), Mansoura University, 2001.

2) E Hassan, M Rahal, S Shakir, A Meshikhes, H Ramadan, K. Abouelkhair,
S Elhadi, A Almulla , F Almanaa, A Abdelwarith, A Alfaraj: FOLFOX and
Bevacizumab as First Line Treatment In Metastatic Colorectal Cancer
(Experience of a Single Institute). Kasr. El-Aini.J. Clin. Oncol. Nucl. Med.
Vol.3 No. 3-4 July-Oct, 2007.

3) K. Abouelkhair, N Alkholy, M Abuhashim, et al: Matrix
Metalloproteinase-2 and HER-2/neu as Markers of Aggressiveness in Breast
Cancer. The Second Breast- Gynecological International Cancer
Conference BGICC. Cairo, Egypt, Jan 21-22, 2010. Abstract.

4) Ezzeldin M. Ibrahim, Khaled M. Abouelkhair. Clinical outcome of
panitumumab for metastatic colorectal cancer with wild-type KRAS status:
a meta-analysis of randomized clinical trials. J Med Oncol DOI
10.1007/s12032-010-9760-4.

5) Ezzeldin M. Ibrahim, Khaled M. Abouelkhair, Osama A. Al-Masri,
Najeeb C. Chaudry, Ghieth A. Kazkaz: Cetuximab-based Therapy is
Effective in Chemotherapy-naive Patients with Advanced and Metastatic
Non-small-cell Lung Cancer: A Meta-analysis of Randomized Controlled
Trials. Lung DOI 10.1007/s00408-011-9286-3.

6) Ezzeldin M Ibrahim, Khaled M. Abouelkhair, Ghieth A. Kazkaz, Osama
A. Al-Masri, Meteb Al-Foheidi: Risk of second breast cancer in female
Hodgkin’s lymphoma survivors: a meta-analysis. BMC
Cancer 2012, 12:197 doi:10.1186/1471-2407-12-197 Published: 28 May
2012.

7) W. El-Sadda, I. Abdel Halim, K. Abouelkhair, R. Abdel Latif: Induction
chemotherapy using docetaxel, cisplatin and fluorouracil (TPF) followed by
concomitant chemoradiotherapy vs the same concomitant
chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (LASCCHN). Accepted for ESMO, 2012.
Ann Oncol (2012) 23(suppl 9): ix334-ix347 doi:10.1093/annonc/mds402
abstract 1039p. Abstract.

8) Ezzeldin M Ibrahim, Ghieth A Kazkaz, Khaled M Abouelkhair, Mubarak
M Al- Mansour, Turki M Al-Fayae, Meteb Al-Foheidi, Ali M Bayer, Osama
A Al-Masri: Increased risk of second lung cancer in Hodgkin’s lymphoma
survivors: a meta-analysis. Lung Vol (1900, Number (5), Sept. 2012. DOI
10.1007/s00408-012-9418-4.

9) Ezzeldin M Ibrahim, Ghieth A Kazkaz, Khaled M Abouelkhair, Ali M
Bayer, Osama A Elmasri: Sunitinib adverse events in metastatic renal cellcarcinoma: a meta-analysis. Int J Clin Oncol. Vol (17), number 5, Oct.
2012. DOI 10.1007/s10147-012-0497-2.

10) Mario Scartozzi, Riccardo Giampieri, Alessandra Mandolesi, Khaled
Mahmoud Abouelkhair, Cristian Loretelli, Michela Del Prete, Luca
Faloppi, Alessandro Bittoni, Maristella Bianconi, Luca Cecchini, Ezzeldin
M. Ibrahim, Italo Bearzi, Stefano Cascinu: Prognostic stratification of k
RAS wild type colorectal cancer patients receiving irinotecan-cetuximab
treatment: Preliminary results of a prospective study. JOURNAL OF
CLINICAL ONCOLOGY, 2013, Vol (31), 15, ISBN 0732-183X.

11) Adel Denewer, Waleed Elnahas, Osama Hussein, Ashraf Khater, Wael El
sadda, Khaled M. Abouelkhair: Evaluation of Inferior Pedicle Therapeutic
Mammoplasty as a Primary Procedure for Upper Quadrants Early Breast
Cancer. Advances in Breast Cancer Research, 2013, 2, 86-90.
doi:10.4236/abcr.2013.23015.

12) Scartozzi, M, Giampieri, R, Mandolesi, A, Abouelkhair, KM, Loretelli, C,
et al: Molecular biomarkers for a prognostic stratification of K-RAS wild
type colorectal cancer patients receiving irinotecan-cetuximab: Preliminary
results of a prospective study. EUROPEAN JOURNAL OF CANCER,
2013, Vol (49), P S562-S562, ISBN 0959-8049.

13) Abouelkhair KM, Abdulla HA, Abdulatif A, Ashry MS: Factors affecting
DSF in differentiated thyroid cancer; A single’s institute Experience.
Abstract. 5Th international conference of Oncology Center of Mansoura
University, 8-11, April, 2015. Dusit Thani, Cairo.

14) Mario Scartozzi, Riccardo Giampieri, Michela Del Prete, Alessandra
Mandolesi, Luca Faloppi, Khaled Mahmoud Abouelkhair et al: Molecular
selection for colorectal cancer (CRC) patients receiving cetuximab: Final
results of a prospective study. Poster in Journal of Clinical Oncology
33(3_suppl):596-596. January 2015
DOI: 10.1200/jco.2015.33.3_suppl.596. 01/2015.

15) Giampieri, Riccardo, Mandolesi, Alessandra, Abouelkhair, Khaled M,
Loretelli, Cristian et al: Prospective study of a molecular selection profile
for RAS wild type colorectal cancer patients receiving irinotecan cetuximab. Journal of translational medicine, 2015, 13, 1, page 140, ISSN
1479-5876.

16) Think again: MAM Screening in Egypt. Review article. First African
congress in collaboration with the 6Th international conference of Oncology
Center of Mansoura University, 5-7, May 2016. Fairmont Helioplis, Cairo.

17) Dalia Bayoumi, Mona Zaky; Khaled M. Abouelkhair; Dina Abdallah. The
Additive role of 1H-Magnetic Resonance Spectroscopic Imaging to Ensure
Pathological Complete Response after Neoadjuvant Chemotherapy in breast
cancer patients. Pol J Radiol. 2019; 84: e570–e580. Published online 2019
Dec 20. doi: 10.5114/pjr.2019.92282.

18) Adel El-Badrawy, Ahmed Tawfik, Gehad Saleh, Mai Abdel-Naby, Khaled
Abouelkhair, et al. MDCT Evaluation of Hepatic Manifestations in
Malignant Hematological Disorder. Cardiovascular Disorder and Medicine
doi:10.31487/j.CDM. 2020.02.01.